Literature DB >> 9411248

Valvular heart disease associated with fenfluramine-phentermine.

S Rasmussen, B C Corya, R D Glassman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9411248

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke.

Authors:  L E Derby; M W Myers; H Jick
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

Review 2.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

Review 3.  Anti-obesity drug discovery: advances and challenges.

Authors:  Timo D Müller; Matthias Blüher; Matthias H Tschöp; Richard D DiMarchi
Journal:  Nat Rev Drug Discov       Date:  2021-11-23       Impact factor: 112.288
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.